Q BioMed Inc. Discusses The Commercialization of Its FDA Approved Metastatic Bone Pain Drug with The Stock Day Podcast

Apr 27, 12:15 PM
The Stock Day Podcast welcomed Q BioMed Inc. (QBIO)(“the Company”), a biotech acceleration and commercial stage company focused on licensing and acquiring undervalued biomedical assets in the healthcare sector. CEO of the Company, Denis Corin, joined Stock Day host Everett Jolly.